Judgement-led international commercialisation across the UK, China and international markets.
Contact us
Frequently Asked Questions
At what stage should we speak?
Ideally before major international commitments are made. We also support organisations already in-market whose growth has stalled or whose strategy needs to evolve.
Do you only work between the UK and China?
No. The UK-China corridor represents our deepest current experience and ecosystem relationships, while our broader focus is international commercialisation. In MedTech and HealthTech, our work increasingly connects China with both the UK and wider European commercialisation ecosystems.
Do you only provide strategy?
No. Our work can begin with strategic assessment, but where appropriate we remain involved through commercialisation, ecosystem engagement, partnership development, business development and ongoing market representation.
Which sectors do you work with?
Our current areas of particular focus are MedTech & HealthTech and DeepTech. We also selectively support organisations in adjacent innovation-led sectors where our international commercialisation expertise can create meaningful value.
Do you provide regulatory, legal or clinical advice?
No. Where international commercialisation requires regulated or specialist expertise, we work alongside appropriate regulatory, market-access, legal, clinical and other professional specialists.
Do you make introductions?
Yes, where an introduction can create genuine strategic or commercial value. However, XL is not an introduction broker or contact-list service. We first seek to understand the commercial objective, then identify which relationships and ecosystem engagements can help move it forward.